Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells

被引:13
作者
Hu, J
Kelly, P
Bonifacino, A
Agricola, B
Donahue, R
Vanin, E
Dunbar, CE
机构
[1] NHLBI, Mol Hematol Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] St Jude Childrens Res Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA
关键词
D O I
10.1016/S1525-0016(03)00239-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recently, RD114 (feline endogenous retrovirus envelope protein)-pseudotyped retroviral particles have been shown to transduce human NOD/SCID repopulating cells efficiently. In this study, we compared directly transduction of repopulating cells with RD114-pseudotyped vector to that with standard amphotropic vector in the rhesus macaque model. G-CSF/SCF-mobilized CD34(+) rhesus peripheral blood cells were cultured in the presence of SCF, Flt-3 ligand, and MGDF on Retronectin-coated flasks. To assess directly the ability of the two pseudotypes to transduce primitive cells, both vectors were added simultaneously to the target cells every 24 h, for a total of four exposures in 96 h. The cells were reinfused after the animals received 1000 cGy total body irradiation. At the end of transduction, gene marking efficiency of CFU was higher with amphotropic LNL6 vector (mean 88.4%) vs RD114-G1Na vector (mean 18.5%). After long-term engraftment in three animals, total neo gene marking levels were 4-5% in PBMNCs and 1.5-4% in granulocytes. The RD114-G1Na marking levels were consistently higher in granulocytes than in mononuclear cells, while amphotropic LNL6 marking levels were higher in PBMNCs than in granulocytes. The differential gene marking patterns suggest that RD114 and amphotropic vectors may target distinct progenitor or stem cell populations. There was no clear advantage for RD114-pseudotyped vectors in this predictive preclinical model in terms of overall long-term marking levels; however, optimization of transduction conditions by increasing m.o.i. or inducing the receptor could potentially improve results with this novel vector system.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 33 条
  • [1] Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
    Aiuti, A
    Slavin, S
    Aker, M
    Ficara, F
    Deola, S
    Mortellaro, A
    Morecki, S
    Andolfi, G
    Tabucchi, A
    Carlucci, F
    Marinello, E
    Cattaneo, F
    Vai, S
    Servida, P
    Miniero, R
    Roncarolo, MG
    Bordignon, C
    [J]. SCIENCE, 2002, 296 (5577) : 2410 - 2413
  • [2] GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS
    BORDIGNON, C
    NOTARANGELO, LD
    NOBILI, N
    FERRARI, G
    CASORATI, G
    PANINA, P
    MAZZOLARI, E
    MAGGIONI, D
    ROSSI, C
    SERVIDA, P
    UGAZIO, AG
    MAVILIO, F
    [J]. SCIENCE, 1995, 270 (5235) : 470 - 475
  • [3] VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS
    BURNS, JC
    FRIEDMANN, T
    DRIEVER, W
    BURRASCANO, M
    YEE, JK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 8033 - 8037
  • [4] CASSEL A, 1993, EXP HEMATOL, V21, P585
  • [5] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
    Cavazzana-Calvo, M
    Hacein-Bey, S
    Basile, CD
    Gross, F
    Yvon, E
    Nusbaum, P
    Selz, F
    Hue, C
    Certain, S
    Casanova, JL
    Bousso, P
    Le Deist, F
    Fischer, A
    [J]. SCIENCE, 2000, 288 (5466) : 669 - 672
  • [6] GENETIC MARKING SHOWS THAT PH(+) CELLS PRESENT IN AUTOLOGOUS TRANSPLANTS OF CHRONIC MYELOGENOUS LEUKEMIA (CML) CONTRIBUTE TO RELAPSE AFTER AUTOLOGOUS BONE-MARROW IN CML
    DEISSEROTH, AB
    ZU, ZF
    CLAXTON, D
    HANANIA, EG
    FU, SQ
    ELLERSON, D
    GOLDBERG, L
    THOMAS, M
    JANICEK, K
    ANDERSON, WF
    HESTER, J
    KORBLING, M
    DURETT, A
    MOEN, R
    BERENSON, R
    HEIMFELD, S
    HAMER, J
    CALVERT, L
    TIBBITS, P
    TALPAZ, M
    KANTARJIAN, H
    CHAMPLIN, R
    READING, C
    [J]. BLOOD, 1994, 83 (10) : 3068 - 3076
  • [7] Peripheral blood CD34(+) cells differ from bone marrow CD34(+) cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor
    Donahue, RE
    Kirby, MR
    Metzger, ME
    Agricola, BA
    Sellers, SE
    Cullis, HM
    [J]. BLOOD, 1996, 87 (04) : 1644 - 1653
  • [8] Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells
    Donahue, RE
    Dunbar, CE
    [J]. HUMAN GENE THERAPY, 2001, 12 (06) : 607 - 617
  • [9] RETROVIRALLY MARKED CD34-ENRICHED PERIPHERAL-BLOOD AND BONE-MARROW CELLS CONTRIBUTE TO LONG-TERM ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION
    DUNBAR, CE
    COTTLERFOX, M
    OSHAUGHNESSY, JA
    DOREN, S
    CARTER, C
    BERENSON, R
    BROWN, S
    MOEN, RC
    GREENBLATT, J
    STEWART, FM
    LEITMAN, SF
    WILSON, WH
    COWAN, K
    YOUNG, NS
    NIENHUIS, AW
    [J]. BLOOD, 1995, 85 (11) : 3048 - 3057
  • [10] Retroviral gene transduction of adult peripheral blood or marrow-derived CD34(+) cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo
    Emmons, RVB
    Doren, S
    Zujewski, J
    CottlerFox, M
    Carter, CS
    Hines, K
    OShaughnessy, JA
    Leitman, SF
    Greenblatt, JJ
    Cowan, K
    Dunbar, CE
    [J]. BLOOD, 1997, 89 (11) : 4040 - 4046